Mary Kate
Appicelli, MPH
|
Division of
Disease Control, Maine Bureau of Health
|
John Bancroft, MD
|
Maine Pediatric
Specialty Group, Portland
|
Geoff Beckett,
PA-C, MPH
|
Division of
Disease Control, Maine Bureau of Health
|
Norm J. Burnell
|
Hepatitis C
Patient Advocate
|
Alroy Chow, MD
|
Practice of
Gastroenterology, Brunswick
|
Tim Clifford, MD
|
Bureau
of Medical Services, Maine
Department of Human Services
|
Kathleen F.
Gensheimer, MD, MPH
|
Division of
Disease Control, Maine Bureau of Health
|
Joyce S. Harmon
|
Maine Department
of Corrections
|
Alan Kilby, MD
|
Portland
Gastroenterology Associates
|
Paul Kuehnert,
MS, RN
|
Director,
Division of Disease Control, Maine Bureau of Health
|
Helen G. Leddy
|
Hepatitis C
Patient Advocate
|
Ann Lemire, MD
|
Public Health
Division, Department of Health and Human Services, City of
Portland
|
Mike
Munson-Burke, PA-C
|
Portland
Gastroenterology Associates
|
Nate Nickerson,
RN, APN
|
Director, Public
Health Division, Department of Health and Human Services, City of
Portland
|
Joanne Ogden
|
Maine Department
of Mental Health, Mental Retardation, and Office of Substance
Abuse Services
|
Karen O’Rourke,
MPH
|
Maine Center for
Public Health, Augusta
|
Sally Lou
Patterson
|
Division of
Disease Control, Maine Bureau of Health
|
Jane Pringle, MD
|
Ambulatory
Medicine, Maine Medical Center
|
Stephen Sears,
MD, MPH
|
MaineGeneral
Medical Center, Augusta
|
Cindy Tack, LCSW
|
Maine Medical
Center Social Work Department
|
Curt Winchenbach,
MD
|
Maine
Gastroenterology Associates, Portland
|
The
Maine Hepatitis C Infection Needs Assessment Steering Committee wishes
to thank the following individuals for their contribution to the needs
assessment and the report:
Mary
Kate Appicelli, MPH
Robert Burman
Karen O’Rourke, MPH
Judy Storfjell, PhD, RN
Ramya Sundararaman, MD
Anthony Yartel
The
Steering Committee would also like to thank the following organizations
for their financial support of the needs assessment:
Maine
Bureau of Health, Division of Disease Control
Maine Center for Public Health
Glaxo-SmithKline Beecham
Schering
Oncology Biotech
Merck and Company
1 2
3 4 5
DDC Home
|